-5%
Deflazacort, a glucocorticoid, exhibits potent anti-inflammatory effects by inhibiting phospholipase A2, an enzyme involved in prostaglandin synthesis. It also suppresses immune responses by decreasing the release of pro-inflammatory immune mediators, thereby contributing to its immunosuppressive properties.
Flacort is used in the management of a wide range of inflammatory and autoimmune conditions, including:
- Severe allergic and hypersensitivity reactions like anaphylaxis and asthma
- Rheumatoid arthritis, juvenile idiopathic arthritis, polymyalgia rheumatica
- Autoimmune disorders such as systemic lupus erythematosus, dermatomyositis, mixed connective tissue disorders (excluding systemic sclerosis), polyarteritis nodosa, and sarcoidosis
- Dermatological conditions such as pemphigus, bullous pemphigoid, and pyoderma gangrenosum
- Kidney disorders like minimal change nephrotic syndrome and acute interstitial nephritis
- Rheumatic carditis
- Inflammatory bowel diseases like ulcerative colitis and Crohn’s disease
- Ocular inflammations including uveitis and optic neuritis
- Hematological disorders such as autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura
- Certain malignancies, including acute and chronic lymphocytic leukemia, malignant lymphoma, and multiple myeloma
- For immune suppression in transplant recipients
Use only as directed by a registered physician.